Tiziana Life Sciences
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Tiziana Life Sciences generated cash of -$11,335,000, which is less than the previous year. Cash used in financing activities reached the amount of $75,346,000 last year. Net change in cash is therefore $65,624,000.
Cash Flow
| 2011 | -853K | -634K | 1.52M |
|---|---|---|---|
| 2012 | -231K | 135K | 67K |
| 2013 | -101K | 2K | 156K |
| 2014 | -2.17M | 64K | 4.38M |
| 2015 | -5.51M | 0 | 12.14M |
| 2016 | -5.11M | -252K | 1.16M |
| 2017 | -5.85M | -1K | 1.19M |
| 2018 | -3.58M | -788 | 7.91M |
| 2019 | -5.32M | -3K | 1.31M |
| 2020 | -11.33M | -123K | 75.34M |
TILS.L Cash Flow Statement (2011 – 2020)
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 200K | 4.16M | 50.43K | 4.70M | 8.90M | 2.26M | 0 | 0 | 33K | 0 |
Operating activities | ||||||||||
Net income | -26.13M | -7.30M | -6.29M | -6.77M | -7.20M | -8.63M | -3.51M | -283K | -653K | -778K |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 91K | 198K | 12.60K | 11K | 8K | 0 | 0 | 0 | 0 | 0 |
Stock-based compensation expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 21K | 21K | -14K |
| Deferred income tax benefit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 21K | 21K | -14K |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts payable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by operating activities | -11.33M | -5.32M | -3.58M | -5.85M | -5.11M | -5.51M | -2.17M | -101K | -231K | -853K |
Investing activities | ||||||||||
Purchases Of Investments | -120K | 0 | 0 | 0 | -217K | 0 | 0 | -155K | -85K | -744K |
Investments In Property Plant And Equipment | -3K | -3K | 0 | -1K | -35K | 0 | 0 | 0 | 0 | 0 |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 0 | 64K | 0 | 0 | 0 |
Cash generated by investing activities | -123K | -3K | -788 | -1K | -252K | 0 | 64K | 2K | 135K | -634K |
Financing activities | ||||||||||
Common Stock Issued | 75.46M | 1.47M | 9.00M | 1.19M | 453K | 2.63M | 2.00M | 156K | 67K | 1.52M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash used in financing activities | 75.34M | 1.31M | 7.91M | 1.19M | 1.16M | 12.14M | 4.38M | 156K | 67K | 1.52M |
Net Change In Cash | 65.62M | -4.01M | 4.12M | -4.65M | -4.2M | 6.63M | 2.26M | 57K | -29K | 0 |
Cash at end of period | 65.82M | 153K | 4.17M | 48K | 4.70M | 8.90M | 2.26M | 57K | 4K | 33K |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |